VLAIO & MEDVIA - Earmarked funding - call 2024.2

Research

Funding organisation:

Agentschap Innoveren en Ondernemen

What?

The Medvia Call 2024.2 has been opened with a webinar.

You can watch the recording of the webinar here. 


In 2024 MEDVIA – supported by VLAIO – will provide budget (amount to be announced) for earmarked, non-dilutive funding for innovations in biotechnology, medical technology, and digital health technology. 

The projects – combining at least two of the above sectors – should develop disruptive solutions for a clearly defined unmet need in healthcare or pool their research specialties to gain knowledge that will lead to such solutions. The results need to lead to a quantifiable increase in investment and employment in Flanders. 

Your project should connect with one of our four overarching themes: Value-based healthcare, personalized medicine, digital medicine or disruptive health solutions.

Who?

UHasselt can act as a coordinator or research partner, depending on the grant type chosen.

The following grant types are possible:
- Research project
- Development project
- Feasibility study
- cSBO
- ICON
- COOCK+
- TETRA

You can always contact MEDVIA to see within which grant type your proposal fits best.

Application?

Deadline intention to submit: September 17th, 2024

Deadline submission abstracts:  November 5th, 2024

Deadline submission full proposal: Q1, 2025

Regulations?

The regulations and more information can be found on the website. 

More information?

More information can be found on the website.

Please contact research@uhasselt.be if you want to apply.

Deadline

05.11.2024

Contact Hasselt University?

E-mail sarah.szyr@uhasselt.be

Tel. +3211269052